Quality Pharmaceutical Grade Cannabis

CanniMed Therapeutics is focused on providing pharmaceutical-grade products with an emphasis on quality control.

CanniMed Ltd. was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis. Currently we operate under the Access to Cannabis for Medical Purposes Regulations(ACMPR) governed by Health Canada.

Our history is much deeper, however. From 2000 – 2013 our parent company, Prairie Plant Systems, was the sole supplier to Health Canada of medical cannabis. As a result of over a decade and a half of hands-on experience, we have implemented standard procedures and processes that are in line with pharmaceutical manufacturing standards to ensure consistency of our products for Canadian patients.

For more information on CanniMed Therapeutics (CMED:TSX) please fill out the form below.

Request Investor Kit

Name*

Email*

*required.

Related News

BTVLogo1
On TV for more than 16 years, BTV-Business Television, a weekly investor program, features emerging companies and top analysts across the US and Canada to bring investors information to grow their portfolio. Hosted by Taylor Thoen, BTV goes on location, interviewing key executives and showcasing their business to give investors insight before they make a buying decision.

Watch BTV
ceo-clips-footer-logo
Did you know management is one of the top three reasons why investors buy a stock? Meet the CEO before you invest. CEO Clips are 90 second video profiles on companies in the markets designed to help you make an educated investment decision. According to Forbes, 60% of people prefer watching video over reading text. What are you waiting for? We’ve featured over 1000 companies. Discover a new company now!

Watch CEO Clips
Broadcast On

© 2017 Business Television All Rights Reserved